chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt seen by another pharmacist on 9/11 to fill antibiotics for injection site reaction. The pharmacist that saw pt said pt had inflammation on arm at injection site.
1:38pm c/o lt. hand and lower lt. arm numbness post vaccination. 136/90, HR 84, T 97.4, O2sat 98%.  States had surgery on hand due to bones being crushed in an accident and arm goes numb from time to time.  2:04pm released from observation, stated hand feeling somewhat better.
About 5 minutes (425pm) after both vaccines and routine hemoglobin finger poke (POC) pt was seated on the table, turned pale and fainted. She was out for 10 minutes, and after waking was dizzy and light-headed, although some of her pallor had improved. We gave her water and had her continue to rest. When sitting up, she felt nauseated and had one episode of emesis. After that, parent brought her a snack and she felt better. It was then I learned she had slept in late and hadn't eaten or drank much before her appointment with me that day.  She was released with her parents, and walked out of the office by herself.
Pt received covid vaccine @ 1256. At 1326, patient complained of pounding headache and chest pressure. BP 150/93, HR 85, RR 20, O2 sat 100%, temp 98.8. Pt taken to ER for further evaluation. No further care required.
No adverse event; Patient received 0.2mL doses of the presentation of the vial with the dark pink cap instead of the 0.25mL dose of the dark blue cap presentation.; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received 0.2mL doses of the presentation of the vial with the dark pink cap instead of the 0.25mL dose of the dark blue cap presentation.) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    In April 2023, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. In April 2023, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received 0.2mL doses of the presentation of the vial with the dark pink cap instead of the 0.25mL dose of the dark blue cap presentation.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received 0.2mL doses of the presentation of the vial with the dark pink cap instead of the 0.25mL dose of the dark blue cap presentation.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received 0.2mL doses of the presentation of the vial with the dark pink cap instead of the 0.25mL dose of the dark blue cap presentation.).    No concomitant medications were reported.  Doses were administered on 21-Apr-2023 and 28-Apr-2023.  Patients ranged from 10m-5y old.  No treatment medications were reported.  This case contains information for the 2nd of 4th child patients described by the reporter.    This case was linked to US-MODERNATX, INC.-MOD-2023-723264 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-723264:Patient 1
Patient did receive 1st dose of eyes or vaccine and after roughly 7 minutes patient reports she started to feel anxious, dizzy, sweaty and pale.  Patient was triaged this provider.  Able to speak in full sentences without difficulty.  Patient felt this way for roughly 5 minutes.  Throughout the entire encounter patient never reported having any difficulty breathing, facial swelling, tongue swelling, throat closing sensations, rash, hives.  Patient does report that she has had this reaction previously with other injections or blood draws.  Patient was given water and apple juice which does seem to help calm her down greatly and after roughly 5 minutes patient reported feeling normal however did feel nauseous for roughly 10 minutes after vaccine.  Patient was observe for additional 20 minutes which time patient felt like she had complete resolution of all of her symptoms.  No further intervention was had during this encounter.  Vital signs were taken and oxygen was 99 percent and heart rate varied between 90 and 110. Prior to discharge patient's heart rate was less than 90. Of note patient reports that she is 12 weeks pregnant.  Saw OBGYN yesterday and denies any known complications associated with current pregnancy.  Denies any abdominal pain, vaginal bleeding.
Chills, body aches and headache on 6/9 The above symptoms subsided but I have soreness under my left armpit
Pt said he developed "chest tightness, body  aches and weakness" the day after receiving MMR. States symptoms lasted 3-4 days, did not seek medical aid. When he came in a month later, told the RN about his reaction (after receiving his second Hep B shot).
aches and pains; headache and chills; headache and chills; Feverish; had just a little sore arm after the first; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (had just a little sore arm after the first ), HEADACHE (headache and chills), CHILLS (headache and chills), PYREXIA (Feverish) and PAIN (aches and pains) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 21-Jan-2021, the patient experienced LIMB DISCOMFORT (had just a little sore arm after the first ). On 20-Feb-2021, the patient experienced HEADACHE (headache and chills). 20-Feb-2021, the patient experienced CHILLS (headache and chills) and PYREXIA (Feverish). On 21-Feb-2021, the patient experienced PAIN (aches and pains). The patient was treated with PARACETAMOL (TYLENOL) for Feverish and General body pain, at an unspecified dose and frequency. On 21-Feb-2021, HEADACHE (headache and chills), CHILLS (headache and chills), PYREXIA (Feverish) and PAIN (aches and pains) had resolved. At the time of the report, LIMB DISCOMFORT (had just a little sore arm after the first ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient stated he has been shrinking, started before the vaccination Patient was treated with Tylenol for pains, aches and fever Patient stated that he and his wife has same providers   This case was linked to MOD-2021-073474 (Patient Link).   Reporter did not allow further contact
rash on hands, face and neck; Quite red; minimally itchy; This is a spontaneous report from a contactable consumer (daughter). A non-pregnant 82-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: not reported, Expiration date: not reported, Age at vaccination: 82-year-old) via an unspecified route of administration on 21Feb2021 06:15 as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. Medical history and concomitant medications were not reported. On 01Mar2021, patient experienced rash (rash on hands, face, neck), quite red and minimally itchy. Treatment was not received for adverse events. No other vaccine in four weeks. Adverse event: rash (rash on hands, face and neck). Quite red and minimally itchy, after 2 weeks. Adverse event start date: 01Mar2021 Covid was not present prior vaccination. Covid was not tested post vaccination. Known allergies was none. Query was: Please help to confirm the date that you became aware of the adverse events in this report as this effects regulatory reporting timelines. This awareness date is the date you became aware of the occurrence of the reported events. If you are the patient in the case, your awareness date would be the date that you became aware you were experiencing the reported events. If you are not the patient in the case, your awareness date would be the date you became aware of the occurrence of the reported events. This awareness date represents the Pfizer receipt date of the report and reflects the earliest date that any Pfizer colleague learned of the adverse event. If you learned of these events from another Pfizer colleague, please provide the date that the first Pfizer colleague became aware of the events reported, as regulatory reporting due dates are calculated based on the first day that a Pfizer colleague became aware of the adverse events. Please help to confirm who reported the events to you. Is it patient self or other people. Response was: event onset date as 08Mar2021 in evening and reporter was patient's daughter. The outcome of events was not recovered.  Follow-up (12Mar2021, 15Mar2021 and 18Mar2021): New follow up information received in response to mail received in response to query sent regarding confirmation of event onset date and reporter included: query and response from reporter, event onset date as 08Mar2021 in evening and reporter was patient's daughter, event onset date as 08Mar2021 in evening and reporter was patient's daughter.  No follow-up attempts are Possible; information about lot/batch number cannot be obtained.
Mother of pt. That pt on 10/22/09-son states he had two random occasions at school that he found it harder to breathe, causing him to pause and put effort into ea breath. States instances were brief and not to extent that he was alarmed enough to seek medical care-no other episodes to date.
injection site pain/soreness: immediately during dose until 5 days after tinnitus: 22-36 hr post dose nausea: 22-36 hr post dose joint aches: 22-36 hr post dose tiredness: 36-72 hr post dose low grade fever (99.5 - 100.5 F): 37-72 hr post dose delayed or skipped menstrual period
Arm swelled from injection site down to elbow. Still has loose skin on the back of his arm due to the swelling that occurred.
Patient became unconscious shortly after the vaccines were administered. Patient fell off exam table and parent pick him up and placed him on the table. Nursing responded to exam room and found patient unconscious and incontinent of urine. Vital signs were stable. 911 was initiated and patient was taken to ED by ambulance. Patient regained consciousness prior to ambulance arrival. Patient was tearful but alert and oriented x3.
Stomach Flu Like symptoms. Stomach pains a lot of gas and watery stool.  That stopped for a day and then that started again after every meal, no matter how lightly I eat. As of today 11/12 2009, I am still having all the same symptoms. I've been taking Pepto-Bismol, but has not helped.
Not able to talk; Snotty nose; Throwing up; This spontaneous case was reported by a consumer and describes the occurrence of APHASIA (Not able to talk), RHINORRHOEA (Snotty nose) and VOMITING (Throwing up) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Down's syndrome.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced APHASIA (Not able to talk), RHINORRHOEA (Snotty nose) and VOMITING (Throwing up). At the time of the report, APHASIA (Not able to talk), RHINORRHOEA (Snotty nose) and VOMITING (Throwing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
By 10 pm  Saturday- severe joint/body aches, chills, headache ,exhaustion , pounding headache.  Sleepy from 4pm Sat til 11:30 sun am  Showered on Mon evening, Notice rash on injected arm   Tues woke 630am feeling bit better then got exteremely dizzy 830am to the point I was stumbling cause it affected my vision.  Became nauseous and had a severe headache   Called doctor
Vaccine went under temperature excursion; No adverse event; Vaccine went temperature excursion and was administered between 02-MAR-2023 to 28-MAR-2023.; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine went temperature excursion and was administered between 02-MAR-2023 to 28-MAR-2023.), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine went under temperature excursion) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 066H22A) for COVID-19 prophylaxis.     It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 Vaccine.     In March 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In March 2023, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine went temperature excursion and was administered between 02-MAR-2023 to 28-MAR-2023.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine went under temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine went temperature excursion and was administered between 02-MAR-2023 to 28-MAR-2023.), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine went under temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Vaccine went temperature excursion and was administered between 02-MAR-2023 to 28-MAR-2023.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine went under temperature excursion).    No concomitant information was reported. Suspect product dosage text was reported as unknown. It was reported that the day after power was lost in the middle of the day at 12:00 pm and had to placed all vaccine in a frozen bag. Booster vaccines were then transported to another clinic. No symptoms were reported. This case is reported for patient 13 out of 26 patients. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-718370 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718370:master case
This spontaneous report as received from a physician via company representative, and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 14-AUG-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 and lot number J009689 with expiration date of 29-JAN-2015 (route of administration was unknown), which was stored at 33 Fahrenheit (F)Degrees (0.555555556 Celsius) for a total of 1560 hours and then at 34 Fahrenheit (F) Degrees (1.111111111 Celsius) for a total of 336 hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effect were reported nor product quality complaint was involved. This is one of several cases received from the same reporter. Additional information has been requested.
I experienced tingling and numbness in my hands and from calves down to toes on both feet. This started on day 6 after the first dose and lasted a couple days. It was intense and tingling to the point of painful and hard to complete my job. I let my OB know because I am pregnant with due date of 7/22/2021 but they did not feel my symptoms could be pregnancy related. I did not seek further care from my primary care doctor because it subsided.
Onset of fullness in left ear combined with ringing in the ear. Feeling of fullness dissipated, but ringing in left ear has been non-stop and remains ongoing. Disrupts sleep, daily ability to focus and relax is impaired.
Fever of 100 degress, lethargy, pain in arm, unable to lift arm, red raised quarter sized spot on her arm where vaccine was administered. We went to the doctor's office and she was given Keflex 500 mg to take 4 times a day.
In bed for a day and a half; chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (In bed for a day and a half), CHILLS (chills) and MYALGIA (Body aches) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032F21A, 021C21A and 020B21A) for COVID-19 vaccination.     The patient's past medical history included Heart attack in 2019.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (In bed for a day and a half), CHILLS (chills) and MYALGIA (Body aches). On 10-Nov-2021, CHILLS (chills) and MYALGIA (Body aches) had resolved. At the time of the report, ASTHENIA (In bed for a day and a half) had resolved.            No treatment medications were reported.  Patient stated that he was taking a string of medications following a heart attack two years ago.   This case was linked to MOD-2021-382440, MOD-2021-382420 (Patient Link).
came to COVID 19 vaccine clinic as an add on at the end of our day. stated she had never received the vaccine through  interpreter. Upon entering the vaccine data into MIIC, he was found to have had the COVID 19 vaccine in the past. He received Janssen vaccine on 4/1/21 and then received the firs dose of Moderna on 7/8/21.
Received H1N1 vaccine at school. BP 150/90, dizzy, SOB. To hospital ER. Treated and released home with parents. D/c to home.
Date of Admission: 10/12/2022   Date of Discharge: 10/15/2022   Admission Diagnosis: A-fib (CMS/HCC) [I48.91]   Hospital Principal Problem (Discharge Diagnoses): NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC)   All Hospital Problems (Other Diagnoses): Active Hospital Problems   Diagnosis o Principal Problem: NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC) o A-fib (CMS/HCC) o Obesity (BMI 30-39.9) o Hyponatremia
This spontaneous report was received from a medical assistant concerning multiple unspecified patients of unknown age and gender. The patient's concurrent conditions and medical history were not provided. It was reported that, on unspecified dates, the patients were vaccinated with improperly stored doses of ROTATEQ lot # M002254, expiration date: 17-NOV-2017 and lot #: M019690, expiration date: 02-NOV-2017, orally, which had a temperature excursion of 1.9 Celsius Degrees for 17 minutes. It was reported that the temperature excursion was detected with a data logger and that the vaccines had no prior excursions. There were no concomitant medications and adverse effects reported. No product quality complaint was involved. This is one of several reports from the same reporter. Additional information has been requested.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 10-OCT-2011, patient received improperly stored VARIVAX dose 1, from lot # 669601/0138AA expiry 26-JAN-2013. On 12-NOV-2012, the patient received second dose of VARIVAX from lot # 0610AE (dose and expiry date unknown) which was improperly stored. No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
achiness; antibody test showed negative; tiredness; a little bit of fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness), ANTIBODY TEST NEGATIVE (antibody test showed negative), FATIGUE (tiredness) and PYREXIA (a little bit of fever) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (achiness), ANTIBODY TEST NEGATIVE (antibody test showed negative), FATIGUE (tiredness) and PYREXIA (a little bit of fever). At the time of the report, PAIN (achiness), ANTIBODY TEST NEGATIVE (antibody test showed negative), FATIGUE (tiredness) and PYREXIA (a little bit of fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-090605 (Patient Link).
t102.9 on 29OCT94; t105 on 31OCT94; went to ER 31OCT94 dx OM;
Arm soreness, unable to lift arm. Started few hours after administration on  7/22.
Severe dizziness and losing consciousness when standing or sitting. Lasted over 12 hours. Plus chills, sweating, headache, low fever which were symptoms from previous vaccination.
Pt had severe lower back pain.  Pt was sent to the hospital to have it checked out.
Thumb felt funny and kind of numb a few hours after first dose; Thumb felt funny and kind of numb a few hours after first dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received bnt162b2 (Pfizer Covid 19 Vaccine -Solution for injection), administration date 15Jan2022 (Lot number: FJ1614) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), HYPOAESTHESIA (non-serious) all with onset 15Jan2022, outcome "recovered" and all described as "Thumb felt funny and kind of numb a few hours after first dose". Additional information: The caller was a consumer who reports the callers daughter received the first dose Pfizer Covid 19 Vaccine on Saturday, 15Jan2022 with lot: FJ1614. The daughter did not have a whelp. The daughter noticed thumb felt funny and kind of numb a few hours after receiving first dose Pfizer Covid 19 Vaccine on 15Jan2022. The caller does not wish to complete a report for the callers daughter since the issues are fully resolved, the caller thinks its fine.  No follow-up attempts are possible. No further information is expected.  Follow-Up (19Jan2022): Follow-up attempts are completed. No further information is expected.
Mom reports that child has a red circle on arm where vaccine was given and a hard knot, feels some warmth at the area.
8-10cm erythem on L upper arm. Mild erythema warm to tocuh.